• PTSD Heart–Brain Dysregulation in Mice

  2026-08-30

  The reference study identifies a vagus-dependent heart–insula pathway through which sympathetic cardiac overactivation contributes to PTSD-like behavior in mice. Its combination of isoproterenol perturbation, vagotomy, electrophysiology, and propranolol treatment provides a causal framework for studying neurocardiac interactions rather than treating cardiac and brain phenotypes as separate outcomes.

• MK-2206 Dihydrochloride: Akt Pathway Guide

  2026-08-29

  MK-2206 dihydrochloride is an allosteric Akt1/2/3 inhibitor for mechanistic studies of PI3K/Akt/mTOR signaling, apoptosis, and cancer cell death. Its reported isoform potency, phosphorylation-site effects, solubility, and storage requirements support controlled assay design rather than direct clinical inference.

• Anagliptin (SK-0403): From DPP-4 to Vascular Insight

  2026-08-28

  Anagliptin (SK-0403) is more than a glycemic-control tool. This thought-leadership article connects selective DPP-4 inhibition with emerging Kv channel and SERCA pump findings, giving translational researchers a disciplined framework for vascular assay design, mechanistic validation, and product selection.

• Dabigatran Workflows for Thrombin Assays

  2026-08-28

  Build reproducible thrombin inhibition assays with Dabigatran, from concentration planning and sample handling to coagulation readouts and troubleshooting. The workflow also translates endpoint discipline from a major cardiovascular outcomes trial into practical assay design without confusing clinical evidence with direct laboratory validation.

• Omega-3 PUFAs in Neonatal Sevoflurane Neurotoxicity

  2026-08-27

  This study links repeated neonatal sevoflurane exposure to impaired glymphatic transport, phosphorylated tau accumulation, mitochondrial injury, and later cognitive and fine motor deficits. Its main innovation is the finding that maternal omega-3 polyunsaturated fatty acid supplementation preserves AQP4 polarization through PDGF-B/PDGFRβ signaling while improving tau clearance and reducing neurotoxicity.

• Sulfo-NHS-LC-Biotin: Practical Protocol

  2026-08-27

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact cell surfaces. It is suited to biotin-avidin detection and streptavidin-based capture, but not to reversible labeling or intracellular labeling in intact cells.

• Anagliptin: A Mechanism-First Vascular Research Guide

  2026-08-26

  Anagliptin (SK-0403) is a potent DPP-4 inhibitor with an emerging vascular research profile. This mechanism-first guide connects incretin biology with Kv channel modulation and SERCA pump regulation while defining practical boundaries for interpreting rabbit aorta assays.

• Palmitic acid: Handling and Protocol Guide

  2026-08-26

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid input for lipid metabolism, inflammation, insulin signaling, and palmitoylation-related workflows. It is appropriate for freshly prepared solvent-based experiments, but not for aqueous protocols or prolonged storage of prepared solutions.

• Sulfo-NHS-SS-Biotin for SERT Trafficking Assays

  2026-08-25

  Sulfo-NHS-SS-Biotin enables reversible surface-protein labeling that can distinguish transporter abundance from trafficking dynamics. This guide connects its chemistry to the Rab26–SERT mechanism reported in neuroscience and translates that insight into practical assay decisions.

• Ciprofloxacin Hydrochloride in Single-Cell Antibiotic Studie

  2026-08-25

  Ciprofloxacin hydrochloride is more than a conventional fluoroquinolone antibiotic: its DNA damage response can produce growth-dependent, single-cell drug interactions. This article translates recent SOS-response findings into practical assay design, combination screening, and research-use guidance.

• Sulfo-NHS-SS-Biotin Kit: Lab Q&A

  2026-08-24

  This scenario-based guide explains how Sulfo-NHS-SS-Biotin Kit, SKU K1006, supports controlled cell-surface labeling, reversible affinity workflows, and protein or antibody characterization. It connects reagent chemistry with practical controls for viability, cytotoxicity, western blotting, and immunoprecipitation experiments.

• LRIG1 in Salivary Gland Development: scRNA-Seq Insights

  2026-08-24

  This study combines single-cell RNA sequencing with histological validation to define how LRIG1 distribution changes during murine submandibular gland development. Its findings place LRIG1 near acinar and basal progenitor populations and link the protein to developmental cell-state regulation, while also identifying testable transcriptional regulators and human cell-line effects.

• Sulfo-NHS-LC-Biotin: Practical Protocol Guide

  2026-08-23

  Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of accessible primary amines on proteins, peptides, and intact-cell surfaces. It is appropriate for stable detection, capture, or purification with avidin or streptavidin systems, but not for reversible labeling or intracellular labeling of cells with an intact plasma membrane.

• CCG-1423 RhoA Inhibitor: Workflow & Applications

  2026-08-22

  CCG-1423 is a pathway-focused RhoA inhibitor for separating MRTF-A nuclear signaling from actomyosin contractility. This article presents practical workflows for cancer research, apoptosis assays, invasion studies, and carefully controlled exploratory work on RhoA/ROCK-dependent barrier biology.

• Coumestrol for RA and ER Signaling Research

  2026-08-22

  Coumestrol is a phytoestrogen estrogen receptor antagonist that supports both rheumatoid arthritis fibroblast-like synoviocyte studies and broader nuclear receptor assays. Its value lies in pairing estrogen receptor pharmacology with a reference-supported PMAIP1, mitochondrial stress, and ferroptosis workflow.

8722 records 3/582 page Previous Next 12345 下5页 Last page